Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-07 17:30:47 - browse：19

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Fetal surgery at risk from Dobbs and new abortion restrictions

hotspot

WSS

Readout Newsletter: Illumina, CRISPR, Regeneron

U.K. officials, researchers try to ease path for bespoke genetic treatments

Yancopoulos of Regeneron works to expand Dupixent success

Yancopoulos of Regeneron works to expand Dupixent success

Cancer, immunology, HIV research ensnared in fetal tissue politics

Pregnancy ages women, but effects reverse after delivery

Wikipedia

Wikipedia

focus

Apple is now the first public company to be valued at $3 trillion

What to do when lifesaving products contribute to climate change

Heart attack and stroke risk calculators need revising

Yancopoulos of Regeneron works to expand Dupixent success

New air purifier tech could be key to improving indoor air quality

U.K. officials, researchers try to ease path for bespoke genetic treatments

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chinese researcher claims birth of first gene

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth’s Optum accused of antitrust violations in California

explore

Pregnancy ages women, but effects reverse after delivery

As biotech industry slumps, bioscience job market is upside down

What to do when lifesaving products contribute to climate change

As biotech industry slumps, bioscience job market is upside down

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

hotspot

hotspot

hotspot

entertainment